Dissertation Awards
2019 (Cycle 30)
| Role of Oxidative Stress in Cigarette Smoke Induced Developing Germ Cell Death | 2019 (Cycle 30) | $144,947 |
| University of California, Irvine | Environmental Exposure/Toxicology | |
| Smoking's Impact on Influenza Pathogenesis and LIAV Response | 2019 (Cycle 30) | $99,061 |
| University of California, Riverside | Pulmonary Disease | |
| Cancer cells alter protein synthesis rates to drive tumorigenesis | 2019 (Cycle 30) | $135,738 |
| University of California, San Francisco | Cancer | |
| Mediators and Moderators of Combined Varenicline and Naltrexone for Smoking Cessation | 2019 (Cycle 30) | $89,671 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 |
| Scripps Research Institute | Cancer | |
| Spatial-, neighborhood- and healthcare system-related drivers of lung cancer treatment disparities | 2019 (Cycle 30) | $130,116 |
| San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
| Identification of Proteins Involved in 5'OH microRNA Production and Protection | 2019 (Cycle 30) | $133,677 |
| University of California, Los Angeles | Cancer | |
| Evaluating the Impact of Key Parameters on Evaporation of E-cigarette Aerosols | 2019 (Cycle 30) | $133,674 |
| University of California, Los Angeles | Environmental Exposure/Toxicology | |
| Determining How the Intratumoral Environment Confers Stemness in Lung Cancer | 2019 (Cycle 30) | $166,350 |
| University of California, Santa Cruz | Cancer | |
| Characterization of Smoking-Associated Circulating Tumor DNA (ctDNA) for Lung Cancer | 2019 (Cycle 30) | $151,350 |
| University of California, Los Angeles | Cancer | |
| Defining regulators of hematopoietic stem cell self-renewal to prevent and treat blood cancers. | 2019 (Cycle 30) | $166,350 |
| University of California, Santa Cruz | Cancer | |
| Intersecting Inequities: Linking tobacco use to oral health disparities among Blacks and Latinx | 2019 (Cycle 30) | $107,757 |
| University of California, Merced | Tobacco-Use Prevention and Cessation | |
| Developing a Novel Cell-free DNA Methylation Assay for Noninvasive Early Detection of Lung Cancer | 2019 (Cycle 30) | $151,350 |
| Stanford University | Cancer | |
| Acetylation of NFkB in NSCLC resistance models | 2019 (Cycle 30) | $162,909 |
| University of California, San Francisco | Cancer | |
| In situ vaccination of lung cancers with engineered dendritic cells combined with immunotherapy | 2019 (Cycle 30) | $153,894 |
| University of California, Los Angeles | Cancer | |
| Inhibiting a DNA damage control mechanism as a strategy to selectively kill lung cancer cells | 2019 (Cycle 30) | $142,203 |
| University of California, Los Angeles | Cancer | |
| Understanding how perinatal nicotine exposure influences immune establishment and function for life | 2019 (Cycle 30) | $166,350 |
| University of California, Santa Cruz | Pulmonary Disease | |
2019 (Cycle 29)
| Predicting cell-cell interactions in the tumor microenvironment for non-small cell lung carcinoma | 2019 (Cycle 29) | $85,522 |
| Stanford University | Cancer | |
| Effects of Third Hand Smoke on Mitochondrial Genetic/Epigenetics and Their Inheritance Pattern | 2019 (Cycle 29) | $127,360 |
| University of California, Riverside | Environmental Exposure/Toxicology | |
| Total Synthesis of Strictosidine, a Precursor to Vinblastine | 2019 (Cycle 29) | $133,677 |
| University of California, Los Angeles | Cancer | |
| Mechanisms of Persistent Immune Dysregulation Following Early Life Tobacco Smoke Exposure | 2019 (Cycle 29) | $85,841 |
| University of California, Davis | Environmental Exposure/Toxicology | |
| Disparities in Life Course Tobacco Exposure and Breast Cancer Risk | 2019 (Cycle 29) | $101,150 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Selectin-targeted glycocalyx mimetic as a treatment for pulmonary inflammation | 2019 (Cycle 29) | $132,097 |
| University of California, Davis | Pulmonary Disease | |
| Study on maternal smoking during pregnancy and childhood metabolic outcomes | 2019 (Cycle 29) | $89,996 |
| University of California, Los Angeles | Cardiovascular and Cerebrovascular Disease | |
| Neuroimaging to detect brain network differences among heavy drinking smokers treated with different cessation aids | 2019 (Cycle 29) | $45,058 |
| University of California, Los Angeles | Neuroscience of Nicotine Addiction and Treatment | |
2019 (Cycle 28)
| Predicting response to mTOR inhibitors in oral cancer | 2019 (Cycle 28) | $150,867 |
| University of California, San Diego | Oral Disease and Dental Health | |
| Evaluating the health effects of electronic cigarette refill | 2019 (Cycle 28) | $103,350 |
| University of California, Riverside | Environmental Exposure/Toxicology | |
| Increasing Awareness of Smoking Risks with Graphic Warnings | 2019 (Cycle 28) | $103,350 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
| SIKs: Novel Regulators of Cardiomyocyte Plasticity | 2019 (Cycle 28) | $135,846 |
| University of California, San Francisco | Cardiovascular and Cerebrovascular Disease | |
| Total Synthesis of Delavatine A and its Structural Analogues | 2019 (Cycle 28) | $159,924 |
| University of California, Berkeley | Cancer | |
| Synthesis of Noscapinoids for Treatment of Lung Cancer | 2019 (Cycle 28) | $152,688 |
| University of California, Los Angeles | Cancer | |
2018 (Cycle 27)
| Spatial Anlaysis of Tobacco Outlets, Vape Shops and Cannabis | 2018 (Cycle 27) | $101,882 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| Targeted Degradation of Proliferative E2F in Nicotine-Induced Lung Cancers | 2018 (Cycle 27) | $134,659 |
| University of California, Santa Cruz | Cancer | |
| Quantifying of Stem Cell Toxicology with Deep Neural Network | 2018 (Cycle 27) | $136,435 |
| University of California, Riverside | Environmental Exposure/Toxicology | |
| Structural Mechanism of Rb Inactivation in Lung Adenocarcinoma | 2018 (Cycle 27) | $134,659 |
| University of California, Santa Cruz | Cancer | |
| Regulation of Endothelial Inflammatory Responses by GPCRs | 2018 (Cycle 27) | $133,793 |
| University of California, San Diego | Cardiovascular Disease | |
2015 (Cycle 24)
| The Impact of Trade Agreements on Domestic Health Regulation | 2015 (Cycle 24) | $29,293 |
| University of California, Santa Cruz | Industry Influence/Policy | |
| Genomic approaches to identify SCLC biomarkers | 2015 (Cycle 24) | $63,100 |
| Stanford University | Early Diagnosis/Pathogenesis | |
| Predictors of Tobacco Use in Hispanic Americans | 2015 (Cycle 24) | $7,090 |
| San Diego State University Research Foundation | Industry Influence/Policy | |
| Tobacco sensitive regulation of pro-osteogenic promoters | 2015 (Cycle 24) | $63,150 |
| University of California, Riverside | Early Diagnosis/Pathogenesis | |
2014 (Cycle 23)
| Evaluation of Metal Emissions in Electronic Cigarettes | 2014 (Cycle 23) | $62,793 |
| University of California, Riverside | Regulatory Science/New Products | |
| THS exposure results in Insulin Resistance | 2014 (Cycle 23) | $57,053 |
| University of California, Riverside | Environmental Exposure/Toxicology | |
| Hookah, Vascular and Endothelial Function in Humans | 2014 (Cycle 23) | $48,401 |
| University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
| Adolescent social networks, smoking, and loneliness | 2014 (Cycle 23) | $60,303 |
| University of Southern California | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2013 (Cycle 22)
| Lynx1 modulation of alpha6 nicotinic receptors | 2013 (Cycle 22) | $34,560 |
| California Institute of Technology | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Toxicological Evaluation of Thirdhand Smoke | 2013 (Cycle 22) | $60,000 |
| University of California, Riverside | Environmental Exposure/Toxicology | |
| VIRTUALLY SMOKING: HOW ADOLESCENTS PERCEIVE SMOKING IMAGERY | 2013 (Cycle 22) | $64,800 |
| University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
| Cell Motility in Pulmonary Premalignancy | 2013 (Cycle 22) | $64,762 |
| University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
2012 (Cycle 21)
| Lung cancer initiation by inflammatory proteins | 2012 (Cycle 21) | $21,207 |
| University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
| Signaling pathways in tobacco-induced vascular dysfunction | 2012 (Cycle 21) | $59,500 |
| University of California, San Diego | Early Diagnosis/Pathogenesis | |
| Built Environment and Tobacco Use in Homeless Shelters | 2012 (Cycle 21) | $59,781 |
| University of California, Los Angeles | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2011 (Cycle 20)
| Smoking and Post-traumatic Growth Among High Risk Youth | 2011 (Cycle 20) | $57,392 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| A Novel Anti-Cancer Therapy: Inhibition of MUS81-EME1 | 2011 (Cycle 20) | $60,000 |
| University of California, Davis | Cancer | |
| Study of TSNA Signaling Pathway by Targeted Proteomics | 2011 (Cycle 20) | $60,000 |
| University of California, Riverside | General Biomedical Science | |
| De-silencing hypermethylated tumor supressor genes | 2011 (Cycle 20) | $60,000 |
| California Institute of Technology | Pulmonary Disease | |
| Predicting bone teratogenicity of tobacco products in vitro | 2011 (Cycle 20) | $59,825 |
| University of California, Riverside | General Biomedical Science | |
2010 (Cycle 19)
| Notch Enhances Shear-Mediated Arteriogenesis in Cerebrum | 2010 (Cycle 19) | $29,982 |
| University of California, San Francisco | Cardiovascular Disease | |
| Replication Studies of Minor-Groove DNA Adducts | 2010 (Cycle 19) | $60,000 |
| University of California, Riverside | Cancer | |
| Adoption of Tobacco Programs in California Schools | 2010 (Cycle 19) | $47,701 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| HRQoL in Veterans with Chronic PTSD and Tobacco Dependence | 2010 (Cycle 19) | $59,300 |
| Alliant International University | Nicotine Dependence | |
| Investigating Tobacco Industry Research on Polonium-210 | 2010 (Cycle 19) | $54,504 |
| Stanford University | Public Health, Public Policy, and Economics | |
| Synthesis of the anti-cancer norcembranoid inelegnolide | 2010 (Cycle 19) | $59,388 |
| University of California, Irvine | Cancer | |
| In search of a complement system inhibitor targeting C5aR | 2010 (Cycle 19) | $60,000 |
| University of California, Riverside | General Biomedical Science | |
2009 (Cycle 18)
| Fluorescent Probes for DNA Mismatch Detection | 2009 (Cycle 18) | $59,749 |
| California Institute of Technology | Cancer | |
| Synthesis of Anticancer Peroxides | 2009 (Cycle 18) | $10,873 |
| University of California, Irvine | Pulmonary Disease | |
| Molecular therapies against small cell lung cancer | 2009 (Cycle 18) | $60,000 |
| Stanford University | Cancer | |
| Repression of c-Jun oncogene activity in lung cancer | 2009 (Cycle 18) | $58,874 |
| California Institute of Technology | Cancer | |
| Inflammatory mediators & lung cancer progression | 2009 (Cycle 18) | $59,185 |
| University of California, Los Angeles | Cancer | |
| Histone Deacetylation and Anti-inflammatory Response of GR | 2009 (Cycle 18) | $59,798 |
| University of California, Berkeley | General Biomedical Science | |
| Inhibition of ERBB2 expression by polyamides in NSCLC | 2009 (Cycle 18) | $59,082 |
| California Institute of Technology | Cancer | |
| Reactivity of Addicted Users to Advertising Cues | 2009 (Cycle 18) | $30,000 |
| University of California, Irvine | Tobacco-Use Prevention and Cessation | |
| Synthesis of Spirolide-Activators of L-type Calcium Channels | 2009 (Cycle 18) | $60,000 |
| University of California, Santa Barbara | Cardiovascular Disease | |
| Cellular Analysis of BAVM Regression in a Mouse Model | 2009 (Cycle 18) | $60,000 |
| University of California, San Francisco | Cardiovascular Disease | |
| Genomic Profiles in Tobacco Related Metastatic Oral Cancer | 2009 (Cycle 18) | $30,000 |
| University of California, San Francisco | Cancer | |
2008 (Cycle 17)
| Regulation of Integrin Activation | 2008 (Cycle 17) | $59,163 |
| University of California, San Diego | Cardiovascular Disease | |
| Synthesis and Evaluation of Telomerase Inhibitors | 2008 (Cycle 17) | $58,359 |
| University of California, Santa Barbara | General Biomedical Science | |
| Cigarette Smoking and Stress-Coping among Latino Youth | 2008 (Cycle 17) | $60,000 |
| University of Southern California | Tobacco-Use Prevention and Cessation | |
| Synthesis of the Glaciapyrroles, New Anticancer Agents | 2008 (Cycle 17) | $60,000 |
| University of California, Irvine | Cancer | |
| Small molecule gene regulation in lung cancer cells | 2008 (Cycle 17) | $31,667 |
| California Institute of Technology | Cancer | |
| Nicotinic Regulation of Neurogenesis in Adult Hippocampus | 2008 (Cycle 17) | $59,910 |
| University of California, San Diego | Nicotine Dependence | |
| Chromatin Remodeling in Glucocorticoid Resistance of COPD | 2008 (Cycle 17) | $56,648 |
| University of California, San Francisco | Pulmonary Disease | |
| Replication Recovery Through Recombination and Mus81-Mms4 | 2008 (Cycle 17) | $60,000 |
| University of California, Davis | General Biomedical Science | |
| Grainyhead-Like Transcription factor in Airway Epithelium | 2008 (Cycle 17) | $60,000 |
| University of California, Irvine | Pulmonary Disease | |
2007 (Cycle 16)
| NMR studies of the LDL receptor active conformation of ApoE | 2007 (Cycle 16) | $54,267 |
| University of California, Berkeley | Cardiovascular Disease | |
| Total Synthesis of Anticancer Compounds: The Neomangicols | 2007 (Cycle 16) | $55,292 |
| University of California, Berkeley | General Biomedical Science | |
| Neural mechanisms underlying nicotine as a 'gateway' drug | 2007 (Cycle 16) | $60,000 |
| University of California, Irvine | Nicotine Dependence | |
| Size-segregated Chemical Composition of Tobacco Smoke | 2007 (Cycle 16) | $16,652 |
| University of California, Irvine | General Biomedical Science | |
2006 (Cycle 15)
| Effects of nicotine on schizophrenia-like cognitive deficits | 2006 (Cycle 15) | $58,298 |
| University of California, San Diego | Nicotine Dependence | |
| Tobacco smoke and oocyte differentiation from human ES cells | 2006 (Cycle 15) | $60,000 |
| University of California, San Francisco | General Biomedical Science | |
| Synthesis and Evaluation of Anticancer Agent Celogentin C | 2006 (Cycle 15) | $29,500 |
| Stanford University | General Biomedical Science | |
2005 (Cycle 14)
| Effects of side stream tobacco smoke on DNA deletions | 2005 (Cycle 14) | $58,876 |
| University of California, Los Angeles | Cancer | |
| Micro RNA and dopamine-induced dentritic protein synthesis | 2005 (Cycle 14) | $59,000 |
| California Institute of Technology | Nicotine Dependence | |
| A novel total synthesis of brazilin and brazilide A | 2005 (Cycle 14) | $59,191 |
| University of California, Santa Barbara | General Biomedical Science | |
| Cell adhesion at nicotinic synapses | 2005 (Cycle 14) | $59,454 |
| University of California, San Diego | Nicotine Dependence | |
| Inhibition of cell death in head and neck cancer cells | 2005 (Cycle 14) | $24,148 |
| University of Southern California | Cancer | |
| Lung cancer treatment: The total synthesis of ineleganolide | 2005 (Cycle 14) | $59,700 |
| California Institute of Technology | General Biomedical Science | |
| Nicotine synapse formation in the hippocampus | 2005 (Cycle 14) | $59,500 |
| University of California, San Diego | Nicotine Dependence | |
| Defining mutagenesis pathways in tobacco-related cancer | 2005 (Cycle 14) | $58,993 |
| Scripps Research Institute | Cancer | |
2004 (Cycle 13)
| Total synthesis of the clinical anticancer drug etoposide | 2004 (Cycle 13) | $59,900 |
| California Institute of Technology | General Biomedical Science | |
| Smoking, atherosclerosis and MCSF gene variations | 2004 (Cycle 13) | $57,480 |
| University of Southern California | Cardiovascular Disease | |
| Cognitive effects of gestational nicotine | 2004 (Cycle 13) | $60,000 |
| University of California, Irvine | General Biomedical Science | |
| Transcription factor modification: A role in lung cancer? | 2004 (Cycle 13) | $6,097 |
| California Institute of Technology | Cancer | |
2003 (Cycle 12)
| Quantification of toxicants in harm reduction cigarettes | 2003 (Cycle 12) | $25,390 |
| University of California, Riverside | General Biomedical Science | |
| Role of regulation orientation on framing antismoking ads | 2003 (Cycle 12) | $60,000 |
| University of California, Irvine | Public Health, Public Policy, and Economics | |
| Latino and Asian American college students' smoking | 2003 (Cycle 12) | $59,500 |
| University of California, Riverside | Epidemiology | |
| Implementation of tobacco prevention programming and smoking | 2003 (Cycle 12) | $58,557 |
| University of Southern California | Epidemiology | |
| New methods for searching tobacco industry documents | 2003 (Cycle 12) | $59,551 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Soluble homologs of the nicotinic receptor | 2003 (Cycle 12) | $52,858 |
| University of California, San Diego | Nicotine Dependence | |
2002 (Cycle 11)
| The determinants of college smoking | 2002 (Cycle 11) | $48,782 |
| University of Southern California | Epidemiology | |
| Cigarette smoke, MCP-1 expression in vivo and atherogenesis | 2002 (Cycle 11) | $50,418 |
| University of California, Riverside | Cardiovascular Disease | |
| Effective diffusion of evidence-based tobacco curricula | 2002 (Cycle 11) | $47,747 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| Total Synthesis of Mitomycin C, an Anti-Cancer Therapeutic | 2002 (Cycle 11) | $59,947 |
| California Institute of Technology | Cancer | |
| Smoking, metabolic syndrome and subclinical atherosclerosis | 2002 (Cycle 11) | $23,772 |
| University of Southern California | Epidemiology | |
| Lobeline: total synthesis and derivitization | 2002 (Cycle 11) | $60,000 |
| California Institute of Technology | General Biomedical Science | |
2001 (Cycle 10)
| Long-term adherence after pulmonary rehabilitation for COPD | 2001 (Cycle 10) | $56,118 |
| University of California, San Diego | Pulmonary Disease | |
| The effect of depression and peer influences on smoking initiation | 2001 (Cycle 10) | $53,300 |
| University of Southern California | Epidemiology | |
| Effects of nicotine on taste processing | 2001 (Cycle 10) | $24,834 |
| University of California, Davis | Nicotine Dependence | |
| Exploring transdisciplinary scientific collaboration | 2001 (Cycle 10) | $29,040 |
| University of California, Irvine | Public Health, Public Policy, and Economics | |
2000 (Cycle 9)
| Effect of estrogen on ETS-induced glyco-oxidation | 2000 (Cycle 9) | $24,692 |
| University of California, Davis | Cardiovascular Disease | |
| Emotional intelligence and smoking across ethnicity | 2000 (Cycle 9) | $52,392 |
| University of Southern California | Epidemiology | |
| Impact of nicotinic signaling on neuronal gene expression | 2000 (Cycle 9) | $30,055 |
| University of California, San Diego | Nicotine Dependence | |
| Relationships between smoking, homocysteine & folate | 2000 (Cycle 9) | $48,651 |
| University of California, San Diego | Epidemiology | |
| Smoking in Asian youth: effect of self-image and family | 2000 (Cycle 9) | $60,000 |
| California School of Professional Psychology | Epidemiology | |
| Mechanism of apparent long-term nicotinic inactivation | 2000 (Cycle 9) | $20,565 |
| University of California, Riverside | Nicotine Dependence | |
| Heat shock proteins as biomarkers of lung oxidant stress | 2000 (Cycle 9) | $24,338 |
| University of California, Davis | Pulmonary Disease | |
| Patterns & risk factors for adolescent smoking progression | 2000 (Cycle 9) | $47,521 |
| University of Southern California | Epidemiology | |
| Nicotine regulation of the noradrenergic system | 2000 (Cycle 9) | $52,375 |
| University of California, Irvine | Nicotine Dependence | |
1999 (Cycle 8)
| Modeling the relation of smoking to the ovarian function | 1999 (Cycle 8) | $53,448 |
| University of California, Davis | Epidemiology | |
| Pregnancy complications and chemokine expression in smokers | 1999 (Cycle 8) | $24,543 |
| University of California, San Francisco | General Biomedical Science | |
| Effects of Nicotine on Brain Development | 1999 (Cycle 8) | $55,404 |
| Cedars-Sinai Medical Center | Nicotine Dependence | |
| An RNA biomarker for tobacco smoke toxicity | 1999 (Cycle 8) | $51,751 |
| University of California, Davis | General Biomedical Science | |
| Parental and Movie Influences on Adolescent Smoking Behavior | 1999 (Cycle 8) | $50,793 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
| Methyl-DNA Binding Protein Regulation and Function | 1999 (Cycle 8) | $54,546 |
| University of California, San Diego | General Biomedical Science | |
| Media and smoking among adolescent girls across ethnicity | 1999 (Cycle 8) | $53,987 |
| University of Southern California | Public Health, Public Policy, and Economics | |
| Tobacco, Bacteria-Binding and Ca Signaling in Lung Epithelia | 1999 (Cycle 8) | $49,426 |
| University of California, Berkeley | Pulmonary Disease | |
| Environmental tobacco smoke effects on lung surfactant | 1999 (Cycle 8) | $47,656 |
| University of California, Santa Barbara | Pulmonary Disease | |
| Nicotinic modulation of dopamine release during development | 1999 (Cycle 8) | $25,698 |
| University of California, Irvine | Nicotine Dependence | |